Salona Global Medical Device (TSE:EVMT) has released an update.
Evome Medical Technologies has unveiled its low-capital expenditure growth strategy, which focuses on enhancing clinical devices and digital applications in line with Biodex’s proficiency in various rehabilitation areas. The company aims to expand market reach through its global distribution network and leverage the Biodex brand’s strong reputation to increase sales, with plans to acquire or license new products every quarter starting Q4 of this year.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.
